Download PDF
Semin Respir Crit Care Med 2007; 28(2): 171-181
DOI: 10.1055/s-2007-976489
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Respiratory Syncytial Virus Infection in Adults

Ann R. Falsey1 , 2
  • 1Department of Medicine, Infectious Diseases Unit, Rochester General Hospital, Rochester, New York
  • 2Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York
Further Information

Publication History

Publication Date:
25 April 2007 (online)

    Permissions and Reprints

ABSTRACT

Respiratory syncytial virus (RSV) is a common wintertime respiratory virus that affects persons of all ages and is the major cause of serious lower respiratory tract infections in young children. However, RSV is also an important pathogen in adults, particularly in the elderly, patients with chronic lung disease, or those with impaired immunity. Clinical features of RSV infections overlap with other respiratory viruses, so laboratory tests are required to establish the diagnosis. Reverse transcriptase polymerase chain reaction (RT-PCR) of samples from nasal swabs, sputum, or bronchoalveolar lavage is a sensitive test to substantiate the diagnosis. Serologies are useful in epidemiological surveys. The clinical course of RSV infections is variable. In infants, RSV presents as bronchiolitis. In adults, mild to moderate upper respiratory tract illness is characteristic. However, severe pneumonia can occur, particularly in the elderly with comorbidities or compromised immune status. Humoral antibodies confer partial immunity to RSV infection and disease severity; cellular immunity is important to eradicate RSV in established infections. Treatment of RSV infections is often supportive. Aerosolized ribavirin is approved for RSV infections in infants; its role in adults is controversial. Infection control measures are critical to limit spread of RSV. Currently, RSV vaccines are not available, but candidate vaccines are being developed.

KEYWORDS

Respiratory syncytial virus (RSV) - respiratory viruses - lower respiratory tract infection

REFERENCES

  • 1 Chanock R, Roizman B, Myers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA).  Am J Hyg. 1957;  66 281-290
    PubMedGoogle Scholar
  • 2 Dowell S F, Anderson L J, Gary Jr H E et al.. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults.  J Infect Dis. 1996;  174 456-462
    CrossrefPubMedGoogle Scholar
  • 3 Fleming D M, Cross K W. Respiratory syncytial virus or influenza?.  Lancet. 1993;  342 1507-1510
    PubMedGoogle Scholar
  • 4 Thompson W W, Shay D K, Weintraub E et al.. Mortality associated with influenza and respiratory syncytial virus in the United States.  JAMA. 2003;  289 179-186
    CrossrefPubMedGoogle Scholar
  • 5 Falsey A R, Hennessey P A, Formica M A, Cox C, Walsh E E. Respiratory syncytial virus infection in elderly and high-risk adults.  N Engl J Med. 2005;  28 1749-1759
    PubMedGoogle Scholar
  • 6 La Montagne J R. RSV pneumonia, a community-acquired infection in adults.  Lancet. 1997;  349 149
    CrossrefPubMedGoogle Scholar
  • 7 Griffin M, Coffey C S, Neuzil K M, Mitchel E F, Wright P F, Edwards K. Winter viruses: influenza and respiratory syncytial virus-related morbidity in chronic lung disease.  Arch Intern Med. 2002;  162 1229-1236
    CrossrefPubMedGoogle Scholar
  • 8 Englund J A, Sullivan C J, Jordan M C, Dehner L P, Vercellotti G M, Balfour H H. Respiratory syncytial virus infection in immunocompromised adults.  Ann Intern Med. 1988;  109 203-208
    PubMedGoogle Scholar
  • 9 Mullooly J P, Bridges C B, Thompson W W et al.. Influenza and RSV-associated hospitalizations.  Vaccine. 2007;  25 846-855
    CrossrefPubMedGoogle Scholar
  • 10 Collins P. The molecular biology of human respiratory syncytial viruses (RSV) of the genus Pneumovirus . In: Kingsbury DW The Paramyxoviruses. Plenum 1991: 103-162
    Google Scholar
  • 11 Walsh E E, Hall C B, Briselli M, Brandriss M W, Schlesinger J J. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection.  J Infect Dis. 1987;  155 1198-1204
    PubMedGoogle Scholar
  • 12 Walsh E E, Schlesinger J J, Brandriss M. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies.  Infect Immun. 1984;  43 756-758
    PubMedGoogle Scholar
  • 13 Johnson P R, Spriggs M K, Olmsted R A, Collins P L. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.  Proc Natl Acad Sci USA. 1987;  84 5625-5629
    CrossrefPubMedGoogle Scholar
  • 14 Johnson P R, Olmsted R A, Prince G A et al.. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.  J Virol. 1987;  61 3163-3166
    PubMedGoogle Scholar
  • 15 Walsh E E, McConnochie K M, Long C E, Hall C B. Severity of respiratory syncytial virus infection is related to virus strain.  J Infect Dis. 1997;  175 814-820
    PubMedGoogle Scholar
  • 16 Hall C B. Respiratory syncytial virus and parainfluenza virus.  N Engl J Med. 2001;  334 1917-1928
    PubMedGoogle Scholar
  • 17 Hall C B, Walsh E E, Schnabel K C et al.. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children.  J Infect Dis. 1990;  162 1283-1290
    CrossrefPubMedGoogle Scholar
  • 18 Anderson L J, Hendry R M, Pierik L T, Tsou C, McIntosh K. Multicenter study of strains of respiratory syncytial virus.  J Infect Dis. 1991;  163 687-692
    PubMedGoogle Scholar
  • 19 Agius G, Dindinaud G, Biggar R J et al.. An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings.  J Med Virol. 1990;  30 117-127
    PubMedGoogle Scholar
  • 20 Centers for Disease Control . Epidemiologic notes and reports: respiratory syncytial virus-Missouri.  MMWR. 1977;  26 351
    PubMedGoogle Scholar
  • 21 Garvie D G, Gray J. Outbreak of respiratory syncytial virus infection in the elderly.  BMJ. 1980;  281 1253-1254
    PubMedGoogle Scholar
  • 22 Hart R JC. An outbreak of respiratory syncytial virus infection in an old people's home.  J Infect. 1984;  8 259-261
    CrossrefPubMedGoogle Scholar
  • 23 Mandal S K, Joglekar V M, Khan A S. An outbreak of respiratory syncytial virus infection in a continuing-care geriatric ward.  Age Ageing. 1985;  14 184-186
    CrossrefPubMedGoogle Scholar
  • 24 Public Health Laboratory Service Communicable Diseases Surveillance Centre . Respiratory syncytial virus infection in the elderly 1976-1982.  Br Med J (Clin Res Ed). 1983;  287 1618-1619
    PubMedGoogle Scholar
  • 25 Sorvillo F J, Huie S F, Strassburg M A, Butsumyo A, Shandera W X, Fannin S L. An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly.  J Infect. 1984;  9 252-256
    CrossrefPubMedGoogle Scholar
  • 26 Falsey A R, Treanor J J, Betts R F, Walsh E E. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings.  J Am Geriatr Soc. 1992;  40 115-119
    CrossrefPubMedGoogle Scholar
  • 27 Osterweil D, Norman D. An outbreak of an influenza-like illness in a nursing home.  J Am Geriatr Soc. 1990;  38 659-662
    PubMedGoogle Scholar
  • 28 Hornsleth A, Siggaard-Andersen J, Hjort L. Epidemiology of herpesvirus and respiratory virus infections, I: Serologic findings.  Geriatrics. 1975;  30 61-68
    PubMedGoogle Scholar
  • 29 Arroyo J C, Jordan W, Milligan L. Upper respiratory tract infection and serum antibody responses in nursing home patients.  Am J Infect Control. 1988;  16 152-158
    CrossrefPubMedGoogle Scholar
  • 30 Mathur U, Bentley D W, Hall C B. Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill.  Ann Intern Med. 1980;  93 49-52
    PubMedGoogle Scholar
  • 31 Morales F, Calder M A, Inglis J M, Murdoch P S, Williamson J. A study of respiratory infection in the elderly to assess the role of respiratory syncytial virus.  J Infect. 1983;  7 236-247
    CrossrefPubMedGoogle Scholar
  • 32 Gross P A, Rodstein M, LaMontagne J R et al.. Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home.  Arch Intern Med. 1988;  148 559-561
    CrossrefPubMedGoogle Scholar
  • 33 Nicholson K G, Baker D J, Farquhar A, Hurd D, Kent J, Smith S H. Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly.  Epidemiol Infect. 1990;  105 609-618
    CrossrefPubMedGoogle Scholar
  • 34 Falsey A R, Walsh E E, Betts R F. Serologic evidence of respiratory syncytial virus infection in nursing home patients.  J Infect Dis. 1990;  162 568-569
    PubMedGoogle Scholar
  • 35 Wald T G, Miller B A, Shult P, Drinka P, Langer L, Gravenstein S. Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons?.  J Am Geriatr Soc. 1995;  43 170-174
    CrossrefPubMedGoogle Scholar
  • 36 Orr P H, Peeling R W, Fast M et al.. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly.  Clin Infect Dis. 1996;  23 1240-1245
    PubMedGoogle Scholar
  • 37 Falsey A R, McCann R M, Hall W J et al.. Acute respiratory tract infection in daycare centers for older persons.  J Am Geriatr Soc. 1995;  43 30-36
    CrossrefPubMedGoogle Scholar
  • 38 Hall C B, Long C E, Schnabel K C. Respiratory syncytial virus infections in previously healthy working adults.  Clin Infect Dis. 2001;  33 792-796
    CrossrefPubMedGoogle Scholar
  • 39 Nicholson K G, Kent J, Hammersley V, Esperanza C. Acute viral infections of upper respiratory tract in elderly people living in the community; comparative, prospective, population based study of disease burden.  BMJ. 1997;  315 1060-1064
    PubMedGoogle Scholar
  • 40 Zambon M C, Stockton J D, Clewley J P, Fleming D M. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study.  Lancet. 2001;  358 1410-1416
    CrossrefPubMedGoogle Scholar
  • 41 Fransen H, Heigl Z, Wolontis S, Forsgren M, Svedmyr A. Infections with viruses in patients hospitalized with acute respiratory illness, Stockholm 1963-1967.  Scand J Infect Dis. 1969;  1 127-136
    PubMedGoogle Scholar
  • 42 Fransen H, Sterner G, Forsgren M et al.. Acute lower respiratory illness in elderly patients with respiratory syncytial virus infection.  Acta Med Scand. 1967;  182 323-329
    PubMedGoogle Scholar
  • 43 Hers J FPh, Masurel N, Gans J C. Acute respiratory disease associated with pulmonary involvement in military servicemen in the Netherlands.  Am Rev Respir Dis. 1969;  100 499-506
    PubMedGoogle Scholar
  • 44 Vikerfors T, Grandien M, Olcen P. Respiratory syncytial virus infections in adults.  Am Rev Respir Dis. 1987;  136 561-564
    PubMedGoogle Scholar
  • 45 Kimball A M, Foy H M, Cooney M K, Allan I D, Matlock M, Plorde J J. Isolation of respiratory syncytial and influenza viruses from the sputum of patients hospitalized with pneumonia.  J Infect Dis. 1983;  147 181-184
    PubMedGoogle Scholar
  • 46 Stanek J, Heinz F. On the epidemiology and etiology of pneumonia in adults.  J Hyg Epidemiol Microbiol Immunol. 1988;  1 31-38
    PubMedGoogle Scholar
  • 47 Zaroukian M H, Leader I. Community-acquired pneumonia and infection with respiratory syncytial virus.  Ann Intern Med. 1988;  109 515-516
    PubMedGoogle Scholar
  • 48 Angeles Marcos M A, Camps M, Pumarola T et al.. The role of viruses in the aetiology of community-acquired pneumonia in adults.  Antivir Ther. 2006;  11 351-359
    PubMedGoogle Scholar
  • 49 Beckham J D, Cadena A, Lin J et al.. Respiratory viral infections in patients with chronic obstructive pulmonary disease.  J Infect. 2005;  50 322-330
    CrossrefPubMedGoogle Scholar
  • 50 Buscho R O, Saxtan D, Shultz P S, Finch E, Mufson M A. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis.  J Infect Dis. 1978;  137 377-383
    CrossrefPubMedGoogle Scholar
  • 51 Carilli A P, Gohd R, Gordon W. A virologic study of chronic bronchitis.  N Engl J Med. 1964;  270 123-127
    CrossrefPubMedGoogle Scholar
  • 52 Fagon J-Y, Chastre J. Severe exacerbations of COPD patients: the role of pulmonary infections.  Semin Respir Infect. 1996;  11 109-118
    PubMedGoogle Scholar
  • 53 Glezen W P, Greenberg S B, Atmar R L, Piedra P A, Couch R B. Impact of respiratory virus infections on persons with chronic underlying conditions.  JAMA. 2000;  283 499-505
    CrossrefPubMedGoogle Scholar
  • 54 Gump D W, Phillips C A, Forsyth B R. Role of infection in chronic bronchitis.  Am Rev Respir Dis. 1976;  113 465-474
    PubMedGoogle Scholar
  • 55 Lambert H P, Stern H. Infective factors in exacerbations of bronchitis and asthma.  BMJ. 1972;  3 323-327
    PubMedGoogle Scholar
  • 56 Lamy M E, Pouthier-Simon F, Debacker-Willame E. Respiratory viral infections in hospital patients with chronic bronchitis.  Chest. 1973;  63 336-341
    PubMedGoogle Scholar
  • 57 Rohde G, Wiethege A, Borg I et al.. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.  Thorax. 2003;  58 37-42
    CrossrefPubMedGoogle Scholar
  • 58 Wiselka M J, Kent J, Cookson J B, Nicholson K G. Impact of respiratory infection in patients with chronic chest disease.  Epidemiol Infect. 1993;  111 337-346
    PubMedGoogle Scholar
  • 59 Walsh E E, Falsey A R, Hennessey P A. Respiratory syncytial virus and other infections in persons with chronic cardiopulmonary disease.  Am J Respir Crit Care Med. 1999;  160 791-795
    PubMedGoogle Scholar
  • 60 Sommerville R G. Respiratory syncytial virus in acute exacerbations of chronic bronchitis.  Lancet. 1963;  II 1247-1248
    PubMedGoogle Scholar
  • 61 Borg I, Rohde G, Loseke S et al.. Evaluation of quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases.  Eur Respir J. 2003;  21 944-951
    CrossrefPubMedGoogle Scholar
  • 62 Seemungal T AR, Wedzicha J A. Viral infections in obstructive airway diseases.  Curr Opin Pulm Med. 2003;  9 111-116
    CrossrefPubMedGoogle Scholar
  • 63 Seemungal T, Harper-Owen R, Angshu B et al.. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2001;  164 1618-1623
    CrossrefPubMedGoogle Scholar
  • 64 Wilkinson T MA, Donaldson G C, Johnston S L, Openshaw P JM, Wedzicha J A. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2006;  173 871-876
    CrossrefPubMedGoogle Scholar
  • 65 Schwarze J, O'Donnell D R, Rohwedder A, Openshaw P JM. Latency and persistence of respiratory syncytial virus despite T cell immunity.  Am J Respir Crit Care Med. 2004;  169 801-805
    CrossrefPubMedGoogle Scholar
  • 66 Falsey A R, Formica M A, Hennessey P A, Criddle M, Sullender W M, Walsh E E. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2005;  173 639-643
    CrossrefPubMedGoogle Scholar
  • 67 Falsey A R, Walsh E E. Respiratory syncytial virus infection in adults.  Clin Microbiol Rev. 2000;  13 371-384
    CrossrefPubMedGoogle Scholar
  • 68 Hudgel D W, Lelan Jr L, Selner J C, McIntosh K. Viral and bacterial infections in adults with chronic asthma.  Am Rev Respir Dis. 1979;  120 393-397
    PubMedGoogle Scholar
  • 69 Beasley R, Coleman E D, Hermon Y, Holst P E, O'Donnell T V, Tobias M. Viral respiratory tract infection and exacerbations of asthma in adult patients.  Thorax. 1988;  43 679-683
    PubMedGoogle Scholar
  • 70 Han L L, Alexander J P, Anderson L J. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden.  J Infect Dis. 1999;  179 25-30
    CrossrefPubMedGoogle Scholar
  • 71 Gentile D A, Doyle W J, Zeevi A, Piltcher O, Skoner D P. Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults.  Hum Immunol. 2003;  64 93-98
    CrossrefPubMedGoogle Scholar
  • 72 Heinzmann A, Ahlert I, Kurz T, Beiner B, Deichmann K A. Association study suggests opposite effects of polymorphisms with IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis.  J Allergy Clin Immunol. 2004;  114 671-676
    CrossrefPubMedGoogle Scholar
  • 73 Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families.  Thorax. 2000;  55 1023-1027
    CrossrefPubMedGoogle Scholar
  • 74 Hull J, Ackerman H, Isles K et al.. Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus.  Am J Hum Genet. 2001;  69 413-419
    CrossrefPubMedGoogle Scholar
  • 75 Tal G, Madelberg A, Dalal I et al.. Association between common Toll-like rector 4 mutations and severe respiratory syncytial virus disease.  J Infect Dis. 2004;  189 2057-2063
    CrossrefPubMedGoogle Scholar
  • 76 Lamprecht C L, Krause H E, Mufson M A. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus.  J Infect Dis. 1976;  134 211-217
    PubMedGoogle Scholar
  • 77 Groothuis J R, Simoes E AF, Levin M J et al.. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children.  N Engl J Med. 1993;  329 1524-1530
    CrossrefPubMedGoogle Scholar
  • 78 Groothuis J R, Simoes E AF, Hemming V G. Respiratory Syncytial Virus Immune Gobulin Study Group . Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG).  Pediatrics. 1995;  95 463-467
    PubMedGoogle Scholar
  • 79 Sorrentino M, Powers T. Palivizumab Outcomes Study Group . Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season.  Pediatr Infect Dis J. 2000;  19 1068-1071
    CrossrefPubMedGoogle Scholar
  • 80 Hall C B, Walsh E E, Long C E, Schnabel K C. Immunity to and frequency of reinfection with respiratory syncytial virus.  J Infect Dis. 1991;  163 693-698
    CrossrefPubMedGoogle Scholar
  • 81 Lee FE-H, Walsh E E, Falsey A R, Betts R F, Treanor J J. Experimental infection of humans with A2 respiratory syncytial virus.  Antiviral Res. 2004;  63 191-196
    CrossrefPubMedGoogle Scholar
  • 82 Walsh E E, Peterson D R, Falsey A R. Risk factors for severe respiratory syncytial virus infection in elderly adults.  J Infect Dis. 2004;  189 233-238
    CrossrefPubMedGoogle Scholar
  • 83 Walsh E E, Falsey A R. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.  J Infect Dis. 2004;  190 373-378
    CrossrefPubMedGoogle Scholar
  • 84 Walsh E E, Falsey A R. Age related differences in humoral immune response to respiratory syncytial virus infection in adults.  J Med Virol. 2004;  73 295-299
    CrossrefPubMedGoogle Scholar
  • 85 Graham B S. Immunologic determinants of RSV-induced disease.  Trends Microbiol. 1996;  4 290-293
    CrossrefPubMedGoogle Scholar
  • 86 Openshaw P JM. Immunity and immunopathology to respiratory syncytial virus.  Am J Respir Crit Care Med. 1995;  152 S59-S62
    PubMedGoogle Scholar
  • 87 Miller R A. The aging immune system: primer and prospectus.  Science. 1996;  273 70-74
    CrossrefPubMedGoogle Scholar
  • 88 Abraham G N, Davis M M. Immune System: Functions and Changes Associated with Aging. Bethesda, MD; Report of the Task Force on Immunology and Aging. National Institute of Aging and National Institute of Allergy and Infectious Disease, U.S. Dept. of Health and Human Services 1996. March 15
    Google Scholar
  • 89 Adler W H, Song L, Chopra R. Immune deficiency of aging. In: Powers DC, Morley JE, Coe R Aging, Immunity and Infection. New York, NY; Springer 1994: 66-81
    Google Scholar
  • 90 Pawelec G, Wagner W, Adibzadeh M, Engel A. T cell immunosenescence in vitro and in vivo.  Exp Gerontol. 1999;  34 419-429
    CrossrefPubMedGoogle Scholar
  • 91 Zhang Y, Wang Y, Gilmore X, Xu K, Wyde P R, Mbawuike I N. An aged mouse model for RSV infection and diminished CD8 + CTL responses.  Exp Biol Med. 2002;  227 133-140
    PubMedGoogle Scholar
  • 92 Looney R J, Falsey A, Walsh E, Campbell D. Effect of aging on cytokine production in response to respiratory syncytial virus infection.  J Infect Dis. 2002;  185 682-685
    CrossrefPubMedGoogle Scholar
  • 93 Lee F EH, Walsh E E, Falsey A R et al.. The balance between influenza and RSV specific CD4 T cells secreting IL-10 or IFN gamma in young and healthy elderly subjects.  Mech Ageing Dev. 2005;  126 1223-1229
    CrossrefPubMedGoogle Scholar
  • 94 de Bree G J, Heidema J, van Leewen E MM et al.. Respiratory syncytial virus-specific CD8 + memory T cell responses in elderly persons.  J Infect Dis. 2005;  191 1710-1718
    CrossrefPubMedGoogle Scholar
  • 95 Johnson K M, Bloom H H, Mufson M A, Chanock R M. Natural infection of adults by respiratory syncytial virus: possible relation to mild upper respiratory disease.  N Engl J Med. 1962;  267 68-72
    PubMedGoogle Scholar
  • 96 Hall W J, Hall C B, Speers D M. Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies.  Ann Intern Med. 1978;  88 203-205
    PubMedGoogle Scholar
  • 97 Shapiro J M, Jean R E. Respiratory syncytial virus.  N Engl J Med. 2001;  345 1132-1133 , (correspondence)
    CrossrefPubMedGoogle Scholar
  • 98 Walsh E E, Peterson D R, Falsey A R. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly.  J Infect Dis. 2007;  195 1046-1051
    CrossrefPubMedGoogle Scholar
  • 99 Falsey A R, Cunningham C K, Barker W H et al.. Respiratory syncytial virus and influenza A infections in the hospitalized elderly.  J Infect Dis. 1995;  172 389-394
    CrossrefPubMedGoogle Scholar
  • 100 Simpson J L, Moric I, Wark P, Johnston L, Gibson P G. Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic methods.  J Clin Virol. 2003;  26 339-346
    CrossrefPubMedGoogle Scholar
  • 101 Englund J A, Piedra P, Jewell A, Baxter B B, Whimbey E, Patel K. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.  J Clin Microbiol. 1996;  34 1649-1653
    PubMedGoogle Scholar
  • 102 Falsey A R, McCann R M, Hall W J, Criddle M M. Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults.  J Am Geriatr Soc. 1996;  44 71-73
    PubMedGoogle Scholar
  • 103 Ohm-Smith M J, Nassos P S, Haller B L. Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ Assays for detection of respiratory syncytial virus.  J Clin Microbiol. 2004;  42 2996-2999
    CrossrefPubMedGoogle Scholar
  • 104 Casiano-Colon A E, Hulbert B B, Mayer T K, Walsh E E, Falsey A R. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial infection in adults.  J Clin Virol. 2003;  28 169-174
    CrossrefPubMedGoogle Scholar
  • 105 Borek A P, Clemens S H, Gaskins V K, Aird D Z, Valsamakis A. Respiratory syncytial virus detection by Remel Xpect, Binax NOW RSV, direct immunofluorescent staining, and tissue culture.  J Clin Microbiol. 2006;  44 1105-1107
    CrossrefPubMedGoogle Scholar
  • 106 Fan J, Henrickson K J, Savatski L L. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization (hexaplex) assay.  Clin Infect Dis. 1998;  26 1397-1402
    CrossrefPubMedGoogle Scholar
  • 107 Freymuth F, Vabret A, Gourain S et al.. Epidemiology and diagnosis of respiratory syncytial virus in adults.  Rev Mal Respir. 2004;  21 13-14
    PubMedGoogle Scholar
  • 108 Freymuth F, Eugene G, Vabret A et al.. Detection of respiratory syncytial virus by reverse transcription-PCR and hybridization with a DNA enzyme immunoassay.  J Clin Microbiol. 1995;  33 3352-3355
    PubMedGoogle Scholar
  • 109 Falsey A R, Formica M A, Treanor J J, Walsh E E. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding.  J Clin Microbiol. 2003;  41 4160-4165
    CrossrefPubMedGoogle Scholar
  • 110 Falsey A R, Formica M A, Walsh E E. Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness.  J Clin Microbiol. 2002;  40 817-820
    CrossrefPubMedGoogle Scholar
  • 111 Moore C, Valappil M, Corden S, Westmoreland D. Enhanced clinical utility of the NucliSENS EasyQ RSV A + B assay for rapid detection of respiratory syncytial virus in clinical samples.  Eur J Clin Microbiol Infect Dis. 2006;  25 167-174
    CrossrefPubMedGoogle Scholar
  • 112 Erdman D D, Anderson L J. Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus.  J Clin Microbiol. 1990;  28 2744-2749
    PubMedGoogle Scholar
  • 113 Vikerfors T, Grandien M, Johansson M, Pettersson C-A. Detection of an immunoglobulin M response in the elderly for early diagnosis of respiratory syncytial virus infection.  J Clin Microbiol. 1988;  26 808-811
    PubMedGoogle Scholar
  • 114 Blanco J CG, Boukhvalova M S, Hemming P, Ottolini M, Prince G A. Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection.  Expert Rev Anti Infect Ther. 2005;  3 945-955
    CrossrefPubMedGoogle Scholar
  • 115 Hall C B, McBride J T, Walsh E E et al.. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection.  N Engl J Med. 1983;  308 1443-1447
    PubMedGoogle Scholar
  • 116 Committee on Infectious Diseases . Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections.  Pediatrics. 1996;  97 137-140
    PubMedGoogle Scholar
  • 117 Committee on Infectious Diseases . Use of ribavirin in the treatment of respiratory syncytial virus infection.  Pediatrics. 1993;  92 501-504
    PubMedGoogle Scholar
  • 118 Randolph A G, Wang E EL. Ribavirin for respiratory syncytial virus lower respiratory tract infection.  Arch Pediatr Adolesc Med. 1996;  150 942-947
    PubMedGoogle Scholar
  • 119 Feldman R J, Fidalgo H C, John Jr J F. Respiratory syncytial virus in a cardiac surgery intensive care unit.  J Thorac Cardiovasc Surg. 1994;  108 1152
    PubMedGoogle Scholar
  • 120 Takimoto C H, Cram D L, Root R K. Respiratory syncytial virus infections on an adult medical ward.  Arch Intern Med. 1991;  151 706-708
    CrossrefPubMedGoogle Scholar
  • 121 Liss H P, Bernstein J. Ribavirin aerosol in the elderly.  Chest. 1988;  93 1239-1241
    PubMedGoogle Scholar
  • 122 Englund J A, Piedra P A, Ahn Y-M, Gilbert B E, Hiatt P W. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection.  J Pediatr. 1994;  125 635-641
    PubMedGoogle Scholar
  • 123 Hall C B, Douglas R G, Geiman J M. Respiratory syncytial virus infections in infants: quantitation and duration of shedding.  J Pediatr. 1976;  89 11-15
    CrossrefPubMedGoogle Scholar
  • 124 Hall C B, Douglas R G. Modes of transmission of respiratory syncytial virus.  J Pediatr. 1981;  99 100-103
    CrossrefPubMedGoogle Scholar
  • 125 Graman P S, Hall C B. Epidemiology and control of nosocomial viral infections.  Infect Dis Clin North Am. 1989;  3 815-841
    PubMedGoogle Scholar
  • 126 Madge P, Paton J Y, McColl J H, Mackie P LK. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus.  Lancet. 1992;  340 1079-1083
    CrossrefPubMedGoogle Scholar
  • 127 Falsey A R, Criddle M M, Kolassa J E, McCann R M, Brower C A, Hall W J. Evaluation of a handwashing intervention to reduce respiratory illness rates in senior day-care centers.  Infect Control Hosp Epidemiol. 1999;  20 200-202
    CrossrefPubMedGoogle Scholar
  • 128 Falsey A R, Walsh E E. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.  Vaccine. 1996;  14 1214-1218
    CrossrefPubMedGoogle Scholar
  • 129 Falsey A R, Walsh E E. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly.  Vaccine. 1997;  15 1130-1132
    CrossrefPubMedGoogle Scholar
  • 130 Gonzalez I M, Karron R A, Eichelberger M et al.. Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.  Vaccine. 2000;  18 1763-1772
    CrossrefPubMedGoogle Scholar

Ann R FalseyM.D. 

Infectious Diseases Unit, Rochester General Hospital

1425 Portland Ave., Rochester, NY 14621

Email: ann.falsey@viahealth.org

      >